BRCAAway Phase II Trial
BRCAAway: Phase II Trial of Abiraterone, Olaparib, or Abiraterone + Olaparib in HRR-Mutant Metastatic CRPC

Released: January 30, 2024

Activity

Progress
1
Course Completed